title: Changes of protein kinase Calpha and cyclin D1 expressions in pulmonary arteries from smokers with and without chronic obstructive pulmonary disease.
abstract: The purpose of this study was to investigate the changes of protein kinase Calpha (PKCalpha) and cyclin D1 expressions in pulmonary arteries from smokers with normal lung function and smokers with mild to moderate chronic obstructive pulmonary disease (COPD). The peripheral lung tissues were obtained from 10 non-smokers with normal lung function (non-smoker group), 14 smokers with normal lung function (smoker group), 11 smokers with mild to moderate COPD (COPD group). The morphological changes of pulmonary arteries were observed by HE-staining. The expressions of alpha-smooth muscle actin (alpha-SMA), proliferating cell nuclear antigen (PCNA), PKCalpha and cyclin D1 proteins in pulmonary artery smooth muscle cells (PASMCs) were immunohistochemically determined. The percentages of PCNA-positive cells were taken as the smooth muscle cells proliferation index (PI). The mRNA expressions of PKCalpha and cyclin D1 in PASMCs were evaluated by real-time fluorescence PCR. Morphometrical analysis showed that the ratio of pulmonary artery wall area to total area (WA%) in smoker group and COPD group was significantly greater than that in non-smoker group (P<0.01). The PASMCs proliferation index in smoker group and COPD group was significantly higher than that in nonsmoker group (P<0.01). The protein levels of PKCalpha and cyclin D1 in PASMCs were significantly increased in smoker group and COPD group as compared with non-smoker group (P<0.01). The mRNA expressions of PKCalpha and cyclin D1 in PASMCs were significantly elevated in smoker group and COPD group as compared with non-smoker group (P<0.01). Significant correlations were found between PKCalpha protein and WA% or PI (P<0.01). Correlations between cyclin D1 protein and WA% or PI also existed (P<0.01). The expression of PKCalpha was positively correlated with the expression of cyclin D1 at both protein and mRNA levels (P<0.01). In conclusion, increased expressions of PKCalpha and cyclin D1 might be involved in the pathogenesis of abnormal proliferation of PASMCs in smokers with normal lung function and smokers with mild to moderate COPD.
authors.affiliation: Department of Respiratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. xiangmin166@gmail.com
authors.forename: Min
authors.initials: M
authors.lastname: Xaing
authors.forename: Xiansheng
authors.initials: X
authors.lastname: Liu
authors.forename: Daxiong
authors.initials: D
authors.lastname: Zeng
authors.forename: Ran
authors.initials: R
authors.lastname: Wang
authors.forename: Yongjian
authors.initials: Y
authors.lastname: Xu
mesh_terms: D000368:Aged; D016022:Case-Control Studies; D019938:Cyclin D1 / Q000235:genetics / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009131:Muscle, Smooth, Vascular / Q000378:metabolism; D051571:Protein Kinase C-alpha / Q000235:genetics / Q000378:metabolism*; D011651:Pulmonary Artery / Q000378:metabolism*; D029424:Pulmonary Disease, Chronic Obstructive / Q000378:metabolism*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012907:Smoking / Q000378:metabolism*
chemical_list: C530104:CCND1 protein, human; D012333:RNA, Messenger; D019938:Cyclin D1; C496628:PRKCA protein, human; D051571:Protein Kinase C-alpha
references.citation: Acta Pharmacol Sin. 2003 Jun;24(6):563-8
references.pmid: 12791183
references.citation: Am J Physiol Lung Cell Mol Physiol. 2001 Aug;281(2):L403-11
references.pmid: 11435215
references.citation: Clin Cancer Res. 2008 Apr 15;14(8):2371-7
references.pmid: 18413827
references.citation: Respir Res. 2009 Aug 14;10:76
references.pmid: 19682386
references.citation: Eur Respir J. 2002 Apr;19(4):632-8
references.pmid: 11998991
references.citation: Surgery. 2000 Aug;128(2):192-7
references.pmid: 10922991
references.citation: Crit Care Med. 2001 Jun;29(6):1229-33
references.pmid: 11395610
references.citation: J Biol Chem. 2003 Sep 5;278(36):34709-16
references.pmid: 12794082
references.citation: Nature. 1988 Aug 25;334(6184):661-5
references.pmid: 3045562
references.citation: Microvasc Res. 2004 Sep;68(2):75-103
references.pmid: 15313118
references.citation: Jpn J Cancer Res. 1998 Mar;89(3):315-22
references.pmid: 9600126
references.citation: Mol Cell Biochem. 2001 Sep;225(1-):97-107
references.pmid: 11716370
references.citation: Exp Lung Res. 1991 Nov-Dec;17(6):997-1009
references.pmid: 1769357
references.citation: Eur Respir J. 2008 Nov;32(5):1371-85
references.pmid: 18978137
references.citation: Chin Med J (Engl). 2008 Oct 20;121(20):2070-6
references.pmid: 19080278
references.citation: Genes Dev. 1998 Aug 1;12(15):2245-62
references.pmid: 9694791
references.citation: Front Biosci. 2000 Apr 01;5:D406-23
references.pmid: 10762593
references.citation: Breast Cancer Res Treat. 2006 Jan;95(2):185-94
references.pmid: 16319987
references.citation: Can J Physiol Pharmacol. 1997 Jul;75(7):936-44
references.pmid: 9315363
references.citation: Respir Res. 2005 Nov 01;6:128
references.pmid: 16262900
references.citation: Exp Cell Res. 1997 Oct 10;236(1):117-26
references.pmid: 9344591